Here are four key trends:
• The market is estimated to grow to a value of around $2.5 billion by 2019.
• The market was valued at $1.7 billion in 2014.
• It is expected to grow at a compound annual growth rate of 7.7 percent from 2014 to 2019.
• The changing preference from mechanical implants to biological ones among the population as well as the rising levels of awareness regarding orthobiologics are the driving forces of this market.
More articles on devices:
aap Implantate ends biomaterials line sale negotiations — 5 things to know
5 things to know about X-spine’s newly-launched Irix-A
Government won’t join qui tam action against MiMedx — 6 key concepts
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
